Portfolio Company · Operating Co.

ClinTrial Research

Healthcare Services · Website

backed byTarsadia Investments

CurrentHealthcare Services

ClinTrial Research

a portfolio company of

Tarsadia Investments

Status on record: Current

Investment year: 2025

PE Firm Index

Who owns ClinTrial Research?

ClinTrial Research is listed as a current portfolio company of Tarsadia Investments on Tarsadia Investments' own portfolio page. Tarsadia Investments has owned ClinTrial Research since 2025, per Tarsadia Investments' portfolio page.

From the company's website

ClinTrial Research is a leading clinical research organization in North Carolina, advancing clinical trial recruitment & innovative studies for better health.

Source: clintrialresearch.com, read November 2026

Company Snapshot

ClinTrial Research is a Healthcare Services company. Its owner on record, Tarsadia Investments, is a firm. Tarsadia Investments lists 32 companies in the index, 12 of them in Healthcare Services.

SectorHealthcare Services

Parent PE firmTarsadia Investments

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Tarsadia Investments

Companies in the index: 32

Private investment firm investing across public and private markets.

Read the Tarsadia Investments profile

Questions about ClinTrial Research

Who owns ClinTrial Research?

What sector is ClinTrial Research in?

ClinTrial Research is in Healthcare Services. Classified from the owner's portfolio label.

What else does Tarsadia Investments own in Healthcare Services?

Tarsadia Investments lists 11 other Healthcare Services companies in the index, including Amneal Pharmaceuticals, Asana Biosciences, AvantStay, ChronicleBio and Erasca.

What is ClinTrial Research's website?

ClinTrial Research's website is https://clintrialresearch.com/.

Sources

Tarsadia Investments
https://tarsadia.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with ClinTrial Research and does not provide investment advice.

Other portfolio companies of Tarsadia Investments

6 of 31 shown

Amneal Pharmaceuticals

Pharmaceuticals

Asana Biosciences

Life Sciences / Biotech

AvantStay

Real Estate / Hospitality

See the full Tarsadia Investments portfolio.

Other Healthcare Services companies held by Tarsadia Investments

Amneal Pharmaceuticals Asana Biosciences

AvantStay ChronicleBio Erasca

Fathom

Other Healthcare Services portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Tarsadia Investments

Status: Current

Investment year: 2025

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.